617 filings
Page 13 of 31
8-K
pwggm
1 Apr 19
Departure of Directors or Certain Officers
4:05pm
8-K
bd5wz0my33h7rctsd pp
19 Mar 19
VBI Vaccines to Present at the Oppenheimer 29th Annual Healthcare Conference
1:16pm
CT ORDER
biai3z 0j2mr
11 Mar 19
Confidential treatment order
12:16pm
8-K
msyihcv5
25 Feb 19
VBI Vaccines Provides Corporate Update, Outlook for 2019, and Year-End 2018 Financial Results
5:25pm
8-K
5egf9ul
11 Feb 19
VBI Vaccines Announces Third Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent GBM Patients
2:00pm
8-K
4pv2s61fsp44i v1lc
5 Feb 19
Entry into a Material Definitive Agreement
4:49pm
8-K
6yuz9kui2fysx
16 Jan 19
VBI Vaccines Appoints Blaine McKee to Board of Directors
12:20pm
8-K
qj9nymsrjh1xkcn7
20 Dec 18
VBI Vaccines Announces Phase 2 Clinical Study Design of its Prophylactic CMV Vaccine Candidate
4:10pm
8-K
x2ht bwt4bd
19 Dec 18
Other Events
2:33pm
8-K
g5wtbaezrq6vsk20ouec
17 Dec 18
VBI Vaccines Announces Proposed Public Offering of Common Shares
12:00am
424B5
97hjwo 7s
17 Dec 18
Prospectus supplement for primary offering
12:00am
424B5
6gzffnlp3gn2cf vqqzr
12 Dec 18
Prospectus supplement for primary offering
4:17pm
D
31qdbrel56a0hhich bz
7 Dec 18
$7M in equity, sold $7M, 1 investor
5:26pm
8-K
mp1qg7ijo kqkrnn97hd
6 Dec 18
VBI Vaccines Enters into License and Collaboration Agreement
8:05am
8-K
k9sf 17erow9e
14 Nov 18
Regulation FD Disclosure
12:00am
8-K
ydzpx4 e3ok9uuy
9 Nov 18
VBI Vaccines Announces Third Quarter 2018 Financial Results and Provides Corporate Update
3:13pm
8-K
ojkd0rf575on ffld
24 Oct 18
Other Events
1:42pm
8-K
qmrcwnvd
18 Oct 18
Departure of Directors or Certain Officers
4:30pm